Sfoglia per RIVISTA
HAEMATOLOGICA
Collezione AOU Novara

  

Items : 19

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2024 Jan 1;109(1):245-255. doi: 10.3324/haematol.2023.283251.

2024
AOU Città della Salute di Torino
AOU Novara

Morabito F; Neri A; Di Raimondo F; Petrucci MT; Nappi D; Bertuglia G; Ferretti E; Sgherza N; Rizzi R; Cotzia E; Gozzetti A; Bongarzoni V; Rossini B; Fontana R; Accardi F; Amico V; Amendola A; Vincelli D; Brunori M; Palumbo G; Pompa A; Uccello G; Barilà G; Casaluci GM; Rago A; Ria R; Tarantini G; Offidani M; Cerchione C; et alii...

Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study. in Haematologica / Haematologica. 2024 Aug 15:0. doi: 10.3324/haematol.2024.285638.

2024
AOU Novara

Lazzarotto D; Cerrano M; Papayannidis C; Chiaretti S; Mosna F; Fracchiolla N; Zappasodi P; Imbergamo S; Del Principe MI; Lunghi M; Lussana F; Piccini M; Fumagalli M; Dargenio M; Salutari P; Forghieri F; Da Molin TG; Bonifacio M; Olivi M; Giglio F; Trappolini S; Leoncin M; Mule A; Delia M; Pasciolla C; Grimaldi F; Cambo B; Santoro L; Guolo F; et alii...

Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study. in Haematologica / Haematologica. 2024 Aug 1. doi: 10.3324/haematol.2024.285258.

2024
AOU Novara

Kaiser F; Lunghi M; Cardinali D; Bellomarino V; Beldinanzi M; Starza ID; Malfona F; Basilico CM; Defina M; Mastaglio S; Giglio F; Lazzarotto D; Salutari P; Piccini M; Cardinali V; Pierini A; Fracchiolla NS; Di Biase F; Annunziata M; Di Trani M; Foa R; Chiaretti S;

Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. in Haematologica / Haematologica. 2023 Jul 1;108(7):1793-1802. doi: 10.3324/haematol.2022.281563.

2023
AOU Novara

Pabst T; Vey N; Adès L; Bacher U; Bargetzi M; Fung S; Gaidano G; Gandini D; Hultberg A; Johnson A; Ma X; Müller R; Nottage K; Papayannidis C; Recher C; Riether C; Shah P; Tryon J; Xiu L; Ochsenbein AF;

SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. in Haematologica / Haematologica. 2023 Aug 17. doi: 10.3324/haematol.2023.283863.

2023
AO Ordine Mauriziano
AOU Novara

Lanza F; Gavriilaki E; Drexler B; Cignetti A; Beier F; Szmigielska-Kaplon A; Loschi M; Patriarca A; Drozd-Sokolowska J; Xicoy B; Giammarco S; Desnica L; Ingram W; Zaidi U; Fattizzo B; Tjon JM; Kulagin A; Verheggen I; Eikema DJ; Griffin M; Orvain C; Risitano AM; De la Camara R; De Latour RP;

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy. in Haematologica / Haematologica. 2023 Aug 1;108(8):2101-2115. doi: 10.3324/haematol.2022.282177.

2023
AOU Città della Salute di Torino
AOU Novara

Ramsay AG; Deaglio S; D'Arena G; Allan JN; Furman RR; Vaisitti T; Laurenti L; Gaidano G; Coscia M; Ioannou N; Rossi D; Moia R; Iannello A; Papazoglou D; Arruga F; Rubin M;

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
ASL Cuneo 1
AOU Novara

Cuneo A; Piciocchi A; Vignetti M; Fazi P; Foà R; Del Giudice I; De Propris MS; Nanni M; Molinari MC; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Neri A; De Novi LA; Tani M; Arcari A; Scarfò L; Giordano A; Gottardi D; Liberati AM; Galieni P; Patrizi VB; Deodato M; Musuraca G; Levato L; Marchetti M; Mannina D; et alii...

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. in Haematologica / Haematologica. 2022 Jun 1;107(6):1470-1473. doi: 10.3324/haematol.2021.280325.

2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Laurenti L; Ghia P; Foà R; Trentin L; Pompili M; Tedeschi A; Mauro FR; Del Poeta G; Scarfò L; Autore F; Tomasso A; Di Sevo D; Arena V; Deodato M; Ielo C; Frustaci AM; Piciocchi A; Rughini A; Cassin R; Albano F; Quaglia FM; Pennese E; Moia R; Gentile M; Murru R; Motta M; Coscia M; Visentin A; et alii...

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study. in Haematologica / Haematologica. 2021 Feb 1;106(2):622-625. doi: 10.3324/haematol.2020.250522.

2021
AOU Novara

Hill A; Patriarca A; Zaja F; Jilma B; Mauro FR; Vos JMI; Frederiksen H; Guillet S; Giannotta J; Zaninoni A; Michel M; Fattizzo B; Berentsen S; Barcellini W;

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies. in Haematologica / Haematologica. 2021 Apr 1;106(4):1079-1085. doi: 10.3324/haematol.2019.243428.

2021
AOU Città della Salute di Torino
AOU Novara

Bringhen S; Boccadoro M; Omedé P; Gaidano G; Palumbo A; Montefusco V; Cavo M; Siniscalchi A; Gilestro M; Galieni P; Capra A; Benevolo G; Olivieri A; Musto P; Ballanti S; Liberati AM; Conticello C; Petrucci MT; Bonello F; Mina R;

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.

2020
AOU Città della Salute di Torino
AOU Novara

Bertoni F; Ladetto M; Gaidano G; Cortelazzo S; Piccin A; Ferreri A; Grønbæk K; Molinari A; Santoro A; Jerkeman M; da Silva MG; Zamò A; Novero D; Paulli M; Barbero D; Kolstad A; Mahmoud AM; Schipani M; Ghione P; Favini C; Diop F; Stefoni V; Di Rocco A; Dahl C; Moia R; Kwee I; Evangelista A; Spina V; Eskelund CW; et alii...

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs. in Haematologica / Haematologica. 2020 Jan;105(1):193-200. doi: 10.3324/haematol.2019.219139. Epub 2019 Jun 20.

2020
AOU Città della Salute di Torino
AOU Novara

Corradini P; Cavo M; Offidani M; Liberati AM; Sonneveld P; Hajek R; Nagler A; Ben-Yehuda D; Cascavilla N; Nozzoli C; Ballanti S; Galieni P; Patriarca F; Musto P; Musolino C; Ribolla R; De Paoli L; Di Raimondo F; Spada S; Boccadoro M; Gay F; Montefusco V;

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials. in Haematologica / Haematologica. 2020 Apr;105(4):1074-1080. doi: 10.3324/haematol.2019.220657. Epub 2019 Jun 27.

2020
AOU Città della Salute di Torino
AOU Novara

Montefusco V; Hájek R; Boccadoro M; Bringhen S; Palumbo A; De Paoli L; Romano A; Falcone AP; Zambello R; Giuliani N; Fraticelli V; Paris L; Amico V; Musto P; Innao V; Cangiolosi C; Bernardini A; Oddolo D; Benevolo G; Spada S; Patriarca F; Evangelista A; Liberati AM; Ledda A; Offidani M; Mina R; Larocca A;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Coscia M; Boccadoro M; Gattei V; Gaidano G; Foà R; Massaia M; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Bonello L; Marchetti M; Magliulo D; Rossi D; Pozzato G; Bo MD; Bomben R; Kopecka J; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.

2020
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; Forconi F; Mauro FR; Giudice ID; Peroni D; Kodipad AA; Jabangwe C; Sagiraju S; et alii...

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. in Haematologica / Haematologica. 2019 Aug;104(8):1640-1647. doi: 10.3324/haematol.2018.208272. Epub 2019 Feb 7.

2019
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Di Raimondo F; Montefusco V; Di Toritto TC; Cavo M; Galieni P; Ponticelli E; Benevolo G; Spada S; Offidani M; Musto P; Ballanti S; Gaidano G; Petrucci MT; Mina R; Bringhen S; Boccadoro M; Larocca A;

A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial. in Haematologica / Haematologica. 2018 May;103(5):849-856. doi: 10.3324/haematol.2017.184325. Epub 2018 Feb 22.

2018
AOU Città della Salute di Torino
AO Alessandria
AOU Novara

Ladetto M; Cortelazzo S; Gaidano G; Wiestner A; Piccin A; Liu D; Luminari S; Arcaini L; Rigacci L; Rusconi C; Vitolo U; Omedè P; Zamò A; Evangelista A; Carella AM; Re A; Dal Bo M; D'Agaro T; Ferrero S; Bomben R; Gattei V;

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. in Haematologica / Haematologica. 2015 Apr;100(4):517-24. doi: 10.3324/haematol.2014.108183. Epub 2015 Jan 16.

2015
AOU Novara

Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA;

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. in Haematologica / Haematologica. 2014 Oct;99(10):1611-7. doi: 10.3324/haematol.2014.103853. Epub 2014 Jul 11.

2014
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Bruno B; Passera R; Gaidano G; Petrucci MT; Musto P; Baldini L; Musolino C; Bringhen S; Gay F; Oddolo D; Gilestro M; Aschero S; Ruggeri M; Caltagirone S; Boccadoro M; Omedè P;